Researchers call for clinical trial globalization in Alzheimer’s

A working group led by Jorge Llibre-Guerra, MD, at the School of Medicine, published a perspective piece arguing for including more people from low and middle-income countries in Alzheimer’s clinical trials. “Democratization of clinical trials will ensure that potential treatments are safe, effective, accessible and equitable,” they wrote.
View More Stories